Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis

Transfusion and Apheresis Science

Volumn 31, Issue 2, 2004, Pages 83-88

  Bosch, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

DALI LDL apheresis; LDL cholesterol; LDL hemoperfusion; Lipoprotein (a)

Indexed keywords

ACID CITRATE DEXTROSE; BRADYKININ; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN; ANTICOAGULANT AGENT;

ADSORPTION; ALKALOSIS; ANGIONEUROTIC EDEMA; ANTICOAGULATION; APHERESIS; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; BLOOD VOLUME; DIRECT ADSORPTION OF LIPOPROTEIN APHERESIS; FLUID INTAKE; FLUSHING; HEMOPERFUSION; HOMEOSTASIS; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; IRON METABOLISM; PRACTICE GUIDELINE; PROTHROMBIN TIME; TECHNIQUE; BLOOD; CLINICAL TRIAL; HYPERCHOLESTEROLEMIA; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW; STATISTICS; TIME;

ADSORPTION; ANTICOAGULANTS; BLOOD COMPONENT REMOVAL; BRADYKININ; CLINICAL TRIALS; HOMEOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; HYPOTENSION; LIPOPROTEINS, LDL; TIME;

EID: 14344265754     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.07.002     Document Type: Article

References (21)

1. T. Bosch State of the art of lipid apheresis Artif Organs 20 1996 292 295
2. B.R. Gordon, and S.D. Saal Current status of LDL-apheresis for the therapy of severe hyperlipidemia Curr Opinion Lipidol 7 1996 381 384
3. Expert Panel on Detection Evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
4. B. Angelin Therapy for lowering lipoprotein (a) levels Curr Opinion Lipidol 8 1997 337 341
5. G.R. Thompson LDL apheresis Atherosclerosis 167 2003 1 13
6. P. Schuff-Werner, E. Schütz, W.C. Seyde, T. Eisenhauer, G. Jannings, and V.W. Armstrong Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP) Eur J Clin Invest 19 1989 30 37
7. N. Koga, and Y. Iwata Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia Atherosclerosis 90 1991 9 21
8. T. Bosch, B. Schmidt, W. Kleophas, C. Gillen, V. Otto, and J. Passlick-Deetjen LDL Hemoperfusion-a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood Artif Organs 21 1997 977 981
9. T. Bosch, A. Lennertz, D. Schenzle, J. Dräger for the DALI Study Group Direct adsorption of low-density liporotein and lipoprotein (a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis J Clin Apheresis 17 2002 161 169
10. T. Bosch, A. Lennertz, B. Schmidt, E. Fink, C. Keller, and M. Toepfer DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy and selectivity of direct adsorption of lipoproteins from whole blood Artif Organs 24 2000 81 90
11. T. Bosch, A. Lennertz, and W. Samtleben High-efficiency DALI apheresis using 1250 ml adsorbers in a hypercholesterolemic obese patient: a case report Ther Apher 5 2001 358 363
12. T. Wendler, R. Schilling, A. Lennertz, K. Sodemann, W. Kleophas, and H. Meßner Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study J Clin Apheresis 18 2003 157 166
13. T. Bosch, O. Heinemann, C. Duhr, T. Wendler, C. Keller, and E. Fink Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI Apheresis) in hypercholesterolemic patients-a prospective controlled clinical trial Artif Organs 24 2000 790 796
14. R.A. Bhalerao, S.V. Shetty, A.C. Pinto, S. Rao, and P. Rao Citrate metabolism-a clinical and experimental study Indian J Med Res 66 1977 331 337
15. R. Apsner, M. Schwarzenhofer, K. Derfler, C. Zauner, K. Ratheiser, and A. Kranz Impairment of citrate metabolism in acute heaptic failure Wien Klin Wochenschr 109 1997 123 127
16. K.D. Bhoola, C.D. Figueroa, and K. Worthy Bioregulation of kinins: kallikreins, kininogens and kininases Pharmacol Rev 44 1992 1 67
17. T. Bosch, and T. Wendler Efficacy and safety of DALI-LDL-Apheresis in two patients treated with the angiotensin II-receptor 1-antagonist losartan Ther Apher Dial 8 2004 269 274
18. T. Wendler, A. Lennertz, O. Heinemann, C. Duhr, W. Samtleben, and T. Bosch Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility Int J Artif Organs 23 2000 710 717
19. U. Julius, G. Siegert, and S. Gromeier Intra-individual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system Int J Artif Organs 23 2000 120 199
20. W.O. Richter, M.G. Donner, B. Höfling, and P. Schwandt Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia Metabolism 47 1998 863 868
21. T. Bosch, A. Lennertz, B. Kordes, and W. Samtleben LDL-hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center Ther Apheresis 3 1999 209 221